Article
Identification of eight genes that are potentially involved in tamoxifen sensitivity in breast cancer cells.
Cell research - 1 Jun 2005
Zarubin Tyler, Jing Qing, New Liguo, Han Jiahuai
Abstract excerpt
Although the antiestrogen agent tamoxifen has long been used to treat women with hormone receptor positive invasive breast carcinoma, the mechanisms of its action and acquired resistance to tamoxifen during treatment are largely unknown. A number of studies have revealed that over-activation of some signaling pathways can cause tamoxifen resistance; however, very little information is available regarding the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
